Formulated Minimal-Length Synthetic Small Hairpin RNAs Are Potent Inhibitors of Hepatitis C Virus in Mice With Humanized Livers
Open Access
- 1 January 2014
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 146 (1) , 63-66.e5
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R44AI074256, R43AI074214, R44AI056611)
This publication has 20 references indexed in Scilit:
- Right- and left-loop short shRNAs have distinct and unusual mechanisms of gene silencingNucleic Acids Research, 2012
- Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based MechanismsMolecular Therapy, 2010
- Practical evaluation of a mouse with chimeric human liver model for hepatitis C virus infection using an NS3-4A protease inhibitorJournal of General Virology, 2010
- Rational design of cationic lipids for siRNA deliveryNature Biotechnology, 2010
- Minimal-length short hairpin RNAs: The relationship of structure and RNAi activityRNA, 2009
- Effects of chemical modification on the potency, serum stability, and immunostimulatory properties of short shRNAsRNA, 2009
- The human liver-uPA-SCID mouse: A model for the evaluation of antiviral compounds against HBV and HCVAntiviral Research, 2008
- Small Interfering RNA Targeted to Hepatitis C Virus 5′ NontranslatedRegion Exerts Potent Antiviral EffectJournal of Virology, 2007
- The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwideJournal of Hepatology, 2006
- Hepatitis C Virus Replicons Escape RNA Interference Induced by a Short Interfering RNA Directed against the NS5b Coding RegionJournal of Virology, 2005